Opinion: Regeneron wasn't paying 'kickbacks.' It was helping people pay egregious Medicare copays

Last Wednesday, the Department of Justice filed suit against Regeneron for paying ” tens of millions of dollars in kickbacks” through a foundation that helps patients cover copays associated with Eylea, its macular degeneration drug. Whether or not Regeneron broke the law, the suit illuminates the stupidity, cruelty, and counterproductivity of Medicare’s insistence that patients feel financial pain in order to receive medically necessary therapies.